SOFIA (Bulgaria), December 8 (SeeNews) -Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev acquired 96,000 shares in the company through deals priced at 3 levs ($1.85/1.53 euro) per share on December 7.